Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-19
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, cilt.122, sa.8, ss.582-589, 2021 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 122 Sayı: 8
- Basım Tarihi: 2021
- Doi Numarası: 10.4149/bll_2021_093
- Dergi Adı: BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
- Sayfa Sayıları: ss.582-589
- Anahtar Kelimeler: COVID-19, SARS-CoV-2, thrombosis, antithrombotic therapy, low-molecular-weight heparin, D-dimer, enoxaparin, PROPENSITY SCORE, COAGULOPATHY
- Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet
Özet
OBJECTIVES: Low molecular weight heparin (LMWH) may provide beneficial effects on outcomes of COVID-19. We aimed to examine the impact of LMWH treatment on clinical outcomes (duration of hospitalization, admission to intensive care unit, the requirement for mechanical ventilation, and death) of COVID-19 patients with normal D-dimer levels at admission.